Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (Inhibikase), a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease,...

Corporate Presentation to Highlight Company's Gene Therapies for Cancer and Diabetes AUSTIN, Texas, Sept. 8, 2022 /PRNewswire/ -- Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a...

Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers, today announced that company...

Paramount Global (NASDAQ: PARA; PARAA) today announced that Bob Bakish, President and Chief Executive Officer of Paramount Global, will participate in a question and answer session during the...

Spotlight on the ESG & Sustainability Performance Management expert solution Over 40 customer speakers share best practices using real-world use cases Walking the talk with sustainable practices...